Archive for the ‘Innovation’ Category

Steady Growth of Innovation in India

December 16th, 2014

Our research into patent activity around the world identifies hotspots of innovation and India is no exception.

That is why for the second consecutive year, Thomson Reuters has produced the 2014 State of Innovation India report and awarded prizes to the most innovative companies in the country.

The study showcases twelve leading sectors and analyzes the innovation in each based on patent activity. Additionally, Thomson Reuters presented the India Innovation Awards to recognize innovation and entrepreneurship in India.

Key findings from this year’s report include:

  • Eight of the Top 10 patent filers in India are Indian organizations. Among the top 10 patent filers in India, eight of these are Indian organizations, Tata Consultancy, CSIR, Larsen & Toubro, Crompton Greaves, Infosys, Tata Motors, TVS Motor, Bharat Heavy Electricals. The two non-Indian top filers are Robert Bosch and Samsung India.

  • Computing & Control leads the innovation activity drawing level with pharmaceutical sector. The largest individual sector for innovation in India is Computing & Control, followed closely by Pharmaceuticals. This is the first time Computing & Control has been in the lead.
  • High-tech, mechanical engineering sectors displace the traditional chemical and agricultural. New sectors such as Electric Power Engineering, Building & Construction, Semiconductors & Electronic Components, Lighting & Heating and Engines, and Pumps & Compressors have increased innovation activity year over year.

Download the full report here.

State of Innovation India 2014 - Thomson Reuters

Arvind Pachhapur, Country Head IP & Science, Thomson Reuters India Innovation

Too Big to Innovate?

November 25th, 2014

For companies to get bigger they have to think small.

According to Techonomy founder and CEO David Kirkpatrick, executives around the globe are finding that new ideas and innovations that can generate the most growth are likeliest to emerge in organizations like small start-ups, putting one-time power brands in the position to alter their ways of doing business.

“The $52-billion-a-year health insurer Aetna, for example, has doubled its stock price in the last two years even as its CEO Mark Bertolini has emphasized breaking the company down into smaller units. ‘We’re 163 years old,’ said Bertolini at last year’s Techonomy conference in Arizona, discussing the impact of tech on his business. ‘Is that a plus or minus?’ a moderator asked him. ‘That’s a minus,’ he replied. ‘Some say we have actuaries who’ve been around 163 years. So it’s difficult moving the model. You have to create separate organizations inside the company that are driving these technologies.’ “

Laura GazeLaura Gaze, Director, IP Solutions: It seems counterintuitive, but there is a lot to glean from Kirkpatrick’s insight. Large companies often bear the burden of many hurdles to clear, and as a result, ideas that could truly innovate often get muddied down before they’re able to grab hold. Large companies have the resources that start-ups don’t, and they should utilize these advantages to breed a culture that encourages innovative thinking. Over the past five years, we’ve seen many corporate American mainstays perish simply because they weren’t able to produce this type of culture. It might just be the time for small thinking.

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation , ,

Celebrating 15 Years of Thomson Reuters and Williams Partnership

November 24th, 2014

Roughly 500 million people around the globe watch Formula One racing every year, and Thomson Reuters is proud to be a part of that huge fan base.

At the British Grand Prix in July, we celebrated a successful 15-year partnership between Thomson Reuters and Williams Martini Racing, one of F1’s premiere teams.

Laura GazeLaura Gaze, Director, IP Solutions: The definition of speed has certainly changed since our partnership was originally brokered in 2000. Innovation across the automotive industry has equipped Formula One drivers with some of the most impressive technologies known to man, and the evolution of the Thomson Reuters family in that time has been just as profound. We are always intrigued to see where the future will lead us, as we continue down exciting new roads with our corporate partners across all of our businesses, and we’re proud that our brand has enjoyed such close success with another industry leader.

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation , ,

Thomson Reuters Names 2014 Top 100 Global Innovators

November 6th, 2014

Lots of CEOs talk about innovation, but which companies are putting their money where their mouths are when it comes to driving real innovation? Today, the IP & Science business of Thomson Reuters answered that question with the release of its fourth annual Top 100 Global Innovators list.

The annual study, which is the only purely quantitative ranking of innovation of its kind, recognizes the 100 most innovative organizations globally based on a series of financial and patent-related metrics.

Beyond the list itself, which includes some names you’d expect (Apple, IBM, Google, IBM, Samsung) and some surprises (Blackberry, Huawei, NGK Spark Plug), the Top 100 Innovators report also contains a detailed analysis of company financials, the influence of governmental policies and industry trends.

Following are some of the key findings:

Japan Takes the Lead Among Global Innovators; U.S. Declines 27% Year-Over-Year: Asia is home to the largest share of Top 100 innovators for the first time this year, with 46 of the 100 companies hailing from that region. Of these, 39 are based in Japan, 4 in South Korea, 2 from Taiwan and, for the first time, a Chinese company (Huawei) has made the list. North America follows with 36, down from 46 last year, with 35 companies domiciled in the US and 1 in Canada. Europe contributed 18 honorees, with the largest representation coming from France (7), Switzerland (5) and Germany (4). The United Kingdom is noticeably absent from the Top 100 list again this year, despite aggressive tax legislation in the country designed to spur new innovation.

Top Innovators Doubled Annual Revenue Growth Rate of S&P 500: Thomson Reuters Top 100 Global Innovators outperformed the S&P 500 for the fourth consecutive year, achieving year-over-year market cap weighted revenue growth of 12.6 percent, roughly double the 6.85 percent annual revenue growth generated by S&P 500 companies. The 2014 Top 100 Global Innovators also generated US $3.69 trillion in revenue last year. And, they had an increase in R&D investment of more than double their NASDAQ counterparts; the Top 100 increased R&D spend by 16.9 percent, whereas NASDAQ’s R&D investment jumped by 8.18 percent and S&P 500 by only 3.97 percent.

R&D Spending Growth Accelerates: The 100 organizations in the study spent a combined U.S. $208 trillion on R&D in 2013, the group outspent the constituents of S&P 500 at a rate of 4:1. On a year-over-year basis, Top 100 Global Innovators increased their total R&D spending by nearly 17 percent.

Smartphone Patent Wars Continue to Drive New Innovation: The intense competition in the smartphone space is on clear display in this year’s Top 100 Global Innovators list, with the major players in the smartphone patent wars present: Apple, Microsoft, Samsung, Google and BlackBerry.

Semiconductor Firms Still Leading the Chase: The Semiconductor and Electronic Components industry continued to lead all other industry sectors in 2014, with 21 representative companies, a 9 percent decrease from the previous year, but still a 50 percent increase since the Top 100 program’s inception, when there were just 14 semiconductor companies on the list. Computer hardware was the next most prolific industry, with 13 companies, up 18% over the previous year. The Industrial sector contributed 8 companies to the Top 100 list, displacing the Automotive sector, which contributed 6 companies this year, down from 8 last year.

Pharma Continues to Increase Presence in Top 100: For the second year in a row, a growing number of pharmaceutical companies, including Abbott Laboratories, Johnson & Johnson, Novartis and Roche, have cemented their presence on the Top 100 list by virtue of their strong global patent portfolios. This comes despite the Top 100 methodology favoring fast-moving, hyper-competitive industries such as semiconductors/electronic components and computer hardware, as opposed to pharma, which tends to have longer R&D cycles.

For more information and to download the full report, visit

To view the full Top 100 Innovators graphic, see blow, or click here.

100 info

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation, Patents , , ,

Thomson Reuters to Host Inside Innovation Event on Nov 6

October 23rd, 2014

Thomson Reuters is hosting an exclusive event and you’re invited!

On November 6th, leading U.S. innovators will gather at the Computer History Museum in Mountain View, CA for Inside Innovation: What It Takes to Win.

This free event will include a panel discussion, moderated by Rob Cox from Reuters Breakingviews. and a question and answer session that will help attendees glean insights from some of the most innovative minds at the nation’s top firms and institutions.

Among those set to appear at the event are:

  • Dr. Michael Karasick, VP Innovations, IBM Watson Group
  • Dr. Peter Lee, Head of Research, Microsoft
  • Professor AnnaLee Saxenian, Dean, School of Information, UC Berkeley
  • Jeff Clavier, Founder and Managing Partner, SoftTech VC
  • Tom Reilly, CEO, Cloudera

To RSVP, click here.

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation , , ,

Global Innovation Spikes to Pre-Recession Levels

May 15th, 2014

We’ve released our latest State of Innovation report today that analyzes global patent filing data over the last 5 years. The 2014 edition of the study, which tracks global patent volumes of 12 bellwether industries, charts hottest growth areas, the impact of emerging markets and nascent hotbeds of new economic growth, finds that the overall rate of innovation growth is now at its highest level since the Great Recession.

Following are some of the report’s key findings:

  • Biggest Innovation Gains Since End of Recession: Total, worldwide patent volume increased 26% over the last year, with 11 of the 12 technology areas studied showing increases. All but one of the 11 gainers had double-digit growth.
  • Automotive Safety, Energy Exploration and Smart Kitchen Appliances Drive Largest Gains: The Automotive, Petroleum, and Domestic Appliances technology areas had the greatest year-over-year increases, with each logging a 35% jump in worldwide patent volume over the prior period. Domestic Appliances ranked among the top three leaders for the second consecutive year. Safety-related innovation saw the greatest gains in the Automotive sector; while the Petroleum sector was driven by petroleum and gas exploration, drilling and processing.
  • Emerging Markets & Academic Contributions on Upswing: Increased activity from China and Russia emphasizes the focus on innovation in these regions, as do increased activity on the part of universities and research institutions. More of such entities made it into the Top 10 regional lists than any year in the past.
  • Computing & Peripherals Continue to Lead the Global Pack: The technology area with the largest overall global patent volume continues to be Computing & Peripherals, for the fifth consecutive year, with over 300,000 inventions over the past year. That’s more than double the innovation activity of the next nearest technology area: Telecommunications. All subsectors within Computing & Peripherals showed positive gains, a first since this report’s inception.

To read the full report,

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation , ,

Can the Patent Box Make or Break Pfizer’s AstraZeneca Takeover?

May 1st, 2014

The British government’s incentive program designed to convince companies to locate research-and-development teams in the U.K. may be at the center of Pfizer’s planned takeover of AstraZeneca.

“The United Kingdom has created attractive incentives for companies to manufacture products and maintain and protect intellectual property, and we have seen that capital and jobs have followed these types of incentives,” Pfizer CEO Ian Read said in a Monday-morning statement designed to woo Astra shareholders (via the WSJ).

According to the Journal:

“When the patent box has been fully phased in by 2017, it will mean qualifying companies pay 10% tax on their profits derived from U.K.-held patents, compared with the current rate of 21% (the rate will fall to 20% in April 2015) […] A combined Pfizer and AstraZeneca would be incorporated in the U.K. (but listed in New York), Mr. Read said Monday, and would therefore be better placed to take advantage of the patent-box tax break on any new drugs developed in the U.K.”

Laura GazeLaura Gaze, Director, Thomson Reuters: The incentives under this new tax regime, which companies have been navigating through for the better part of two years, seem as though they are doing exactly as they were intended. But will this new structure derail Pfizer’s plan? This is an extremely complicated deal with many moving parts, so we may not have answers to these questions for a while, but it’s clear the patent box is set to be a very significant item that may decide many corporate agendas in the years to come.

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation, Patents , , , , ,

Would a Ruling Against Aereo Curb American Innovation?

April 30th, 2014

A major Aereo investor said a Supreme Court ruling against the New York-based streaming company could have serious repercussions on American innovation.

Media mogul Barry Diller told CNN that a Supreme Court decision to shut Aereo, a company that streams local broadcast television to customers’ computers, phones and tablets for $8 per month, would have “profound effects on the development of technology.”

“It’s almost like saying, ‘what if there was no telephone?,” Diller told CNN. “If [the Supreme Court justices] stop it—which they very well may—I don’t think it’s the end of any world because we’ll not really know, but I think … if it stops, it will have profound effects on the developments of technology.”

Laura GazeLaura Gaze, Director, Thomson Reuters: It’s an interesting debate. On one hand, Diller obviously has a vested interest, but he does make a reasonable point. While ABC, NBC, Fox and CBS, accuse Aereo of unlawfully transmitting their copyrighted TV content without paying for licenses, Aereo argues that its service is the legal equivalent of selling customers an antenna and a DVR. It does give one pause to wonder what really is the difference? Ultimately, this will come down to the Court’s interpretation of “public performance” under U.S. copyright law, but should Aereo get shut down, it may deal a serious blow to the evolution of streaming platforms.

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation , , ,

Thomson Reuters Study Finds a Global Imbalance in Diabetes Research Funding

April 24th, 2014

The diabetes epidemic continues to surge with the disease affecting an estimated 382 million people worldwide. But a large gap exists in the research and funding, making understanding these ebbs and flows pivotal in continuing to understand the landscape. That’s why we’ve released a new analysis today that identifies the top 34 global funders of diabetes research.

The analysis was conducted by Thomson Reuters ScienceWatch analysts and found that the U.S. National Institutes of Health is the leading funding organization with 13,436 acknowledgements, followed by the National Natural Science Institute of China with 3,354 acknowledgements, and the Juvenile Diabetes Research Foundation (JDRF) with 2,547 acknowledgements. Other top 35 funders include government agencies such as the Canadian Institutes of Health Research; the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the American Heart Association, as well as global pharmaceutical giants such as Novo Nordisk and Pfizer.

However, several regions that are strongly impacted by the disease were notably absent from the list. According to the International Diabetes Federation, an estimated 20 million people live with the disease in Africa, and the continent has the highest global rate of mortality, but no African organizations were listed among the top funding agencies. Africa-based researchers did contribute to 1,581 diabetes-related papers.

In addition, regions of Southeast Asia, the Middle East, and India are similarly afflicted, but their research output does not yet measure up. Sixty five million of India’s 1.2 billion people are affected by diabetes, but no India-based organizations have yet emerged among the 35 most-prolific funders.

To view the infographic that further illustrates this regional imbalance, visit

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation , , ,

Quote: Human Element Integral to Innovation

March 21st, 2014

Speaking at the ad:tech event in Sydney, Australia, Owen Rogers, senior partner at Palo Alto-based design firm IDEO, said the human element of the innovation process is too important to be ignored, and unfortunately, many executives do just that when deciding on a strategy:

“There are three elements to any problem – technical, feasible [business] and the human piece. Everybody typically forgets the human piece, or they devalue it, thinking the technical or business piece has to be overcome first and foremost.”

Laura Gaze, Senior Marketing Manager, IP Solutions Innovation , , , ,